… Our study of immune therapy in recent-onset type 1 diabetes did not show any significant
between-group differences in the primary and secondary outcomes (panel). The primary …

… diabetes, insulin at the dosage used in this study does not delay or prevent type 1 diabetes.
(… Type 1 diabetes mellitus occurs in genetically predisposed persons as a consequence of …

… Type 1 Diabetes TrialNet is an international consortium of clinical research centers aimed
at the prevention or delay of type 1 diabetes (T1D). The fundamental goal of TrialNet is to …

… Research Foundation, has formed Type 1 Diabetes – TrialNet to perform further prevention
… of pre-type 1 diabetes in relatives of persons with the disease. We describe in this study the …

… , a preclinical stage 1 case of type 1 diabetes is defined as the … to overt diabetes, diagnosed
by standard criteria (figure 2B). … Genome-wide association studies have identified over 60 …

… In this study, we aim to evaluate the effect of MI on self-care and HbA1c in people with
type 1 diabetes. Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT03906786, …

… that the overall prevalence of type 1 diabetes is higher in adults than in children, justifying
our focus on type 1 diabetes in adults (1). The global prevalence of type 1 diabetes is 5.9 per …

… On the basis of this study, T1DM is classified as autoimmune diabetes, regardless of the
presence of obesity or insulin resistance, whereas T2DM requires the presence of insulin …

… Best-corrected visual acuity (VA) was measured using a modification of the Early Treatment
Diabetic Retinopathy Study protocol. Visual impairment and severe VI were defined as best-…

… We did a proof-of-concept study to test the efficacy of this approach in patients with
insulindeficient, C-peptide-negative, type 1 diabetes mellitus. The aim was to determine whether …